Placement Pending
Remix Therapeutics placement
US$100m raised
Announced 24 Jun 2026
Advisers
Remix Therapeutics
Issuer
Not disclosed
Lead managers
- Legal adviser
- Placement agent
- Issuer
- Remix Therapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Oncology, Drug Development
Similar deals
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
- Parabilis Medicines IPO Jun 2026 · US$670m · Biotech


